arrow
BackJournal Details
J

Journal of Hematology & Oncology

IF40.4
Papers67
Citations
Journal Papers 66
Publication Date
Plasma biomarkers predicting development of lung cancer 5 years before diagnosis
delete2026-08-14
delete0
deleteOAAI
deleteKostas A. Papavassiliou; Athanasios G. Papavassiliou
deleteShare
deleteSave
Correction: First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignancies
delete2026-08-10
delete0
deleteOAAI
deleteDaruka Mahadevan; Minal Barve; Devalingam Mahalingam; Jay Parekh; Michael Kurman; James Strauss; Larry Tremaine; Robert Hromas; Joshua Sills; John McCulloch; John Harkey; Stacy Suberg; Lisa Zimmerman; Guangrong Zheng; Daohong Zhou
deleteShare
deleteSave
The KRAS targeting revolution in metastatic pancreatic cancer: insights from the landmark RASolute-302 trial and emerging allele-specific strategies at ASCO 2026
delete2026-08-08
delete0
deleteOAAI
deleteSerena Pillozzi; Elisa Giommoni; Giulia Petroni; Daniele Rossini; Daniele Lavacchi; Marco Brugia; Andrea Galli; Lorenzo Antonuzzo
deleteShare
deleteSave
A phase 1 trial of CD123-directed chimeric antigen receptor T-cell therapy in adults with relapsed/refractory acute myeloid leukemia or blastic plasmacytoid dendritic cell neoplasm
delete2026-08-07
delete0
deleteOAAI
deleteLihua E. Budde; Marissa M. Del Real; Joo Song; Tracey Stiller; Yan Wang; Ahmed Aribi; Karamjeet Sandhu; Ryotaro Nakamura; Emanuela C. Marcucci; Jian J. Wu; Kenneth Ng; Mary C. Clark; Brent Wood; Jamie R. Wagner; Jinny Paul; Christine E. Brown; Anthony Stein; Guido Marcucci; M. Suzette Blanchard; Joycelynne Palmer; Stephen J. Forman
deleteShare
deleteSave
A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection
delete2026-07-30
delete0
deleteOAAI
deleteÁngel Ramírez-Fernández; Adham S. Bear; Elahe Kamali; Robert Bartoszek; Matthew Ho; Gregory M. Chen; Devin Dersh; Laura Córdoba-Espejo; Jiageng Liu; Mosha Deng; Miriam Velasco-Sidro; Ankita Jain; Julia Han Noll; Caitlin R Hopkins; Owen Koucky; Janna Minehart; Alexander J. Dimitri; Erik Williams; Maya Lavorando; Alejandro Segura-Tudela; John Scholler; Julie Barber-Rotenberg; Julie K. Jadlowsky; Daniel J. Powell; Anne Chew; Vanessa E. Gonzalez; Donald L. Siegel; Bruce L. Levine; Michael T. Lotze; Carl H. June; James L. Riley; Robert H. Vonderheide; Friederike Herbst; Joseph A. Fraietta
deleteShare
deleteSave
CD20 expression dynamics in adult B-cell acute lymphoblastic leukemia and impact on anti-CD20 treatment
delete2026-07-20
delete0
deleteOAAI
deleteMonika Szczepanowski; Johanna Richter; Sonja Bendig; Lorenz Bastian; Miriam Kelm; Veronika Beck; Thomas Beder; Guranda Chitadze; Michaela Kotrová; Johannes Duell; Christoph Faul; Johannes Gärtner; Alina Hartmann; Britta Kehden; Eva Maria Murga Penas; Martin Neumann; Matthias Ritgen; Wiebke Schrader; Björn Steffen; Heiko Trautmann; Andreas Viardot; Thomas Burmeister; Claudia D. Baldus; Stefan Schwartz; Nicola Gökbuget; Monika Brüggemann
deleteShare
deleteSave
Long-term follow-up of a phase 1/2 trial of anti-GDF-15 antibody visugromab plus anti-PD-1 antibody nivolumab in anti-PD-1/-L1 relapsed/refractory solid tumors
delete2026-07-09
delete0
deleteOAAI
deleteIgnacio Melero; María de Miguel; Elena Garralda Cabanas; Guillermo de Velasco; Markus Joerger; Juan Martín-Liberal; Maria Reig; David König; Joerg Trojan; Maria-Elisabeth Goebeler; Martin Schuler; Guzman Alonso; Reinhard Dummer; Maria E. Rodríguez-Ruiz; Ramón Yarza; Giulia Pretelli; Jorge Esteban-Villarubia; Kira-Lee Koster; Paula Sabat Viltro; Marco Sanduzzi-Zamparelli; Heinz Läubli; Christine Koch; Cyrus Sayehli; Tanja Gromke; Fabricio Racca; Egle Ramelyte; Peter R. Galle; Andrea Necchi; Martin Reck; Zlatko Trajanoski; Hubert Hackl; Falk Gogolla; Jaclyn Billing; Teresa Sattmann; Jörg Wischhusen; Christine Schuberth-Wagner; Julia Akdemir; Felix S. Lichtenegger; Alexandra Auckenthaler; Marlene Fox; Kathrin Klar; Petra Fettes; Mara Liebig; Aasim Amin; Sheena Sachdeva; Frank Hermann; Eugen Leo
deleteShare
deleteSave
From tumor targeting to tumor accessibility: surface-engineered bacteria as precision living therapeutics for translational medicine
delete2026-07-07
delete0
deleteOAAI
deleteLiyuan Qiao; Leyang Wu; Yihan Xiao; Jiahui Qiu; Xinyue Qiao; Xiao Dong; Chengxuan Lei; Wanru Wang; Yuzi Zhao; Zichun Hua
deleteShare
deleteSave
Antibody-oligonucleotide conjugates: design principles, intracellular delivery, and translational opportunities
delete2026-07-06
delete0
deleteOAAI
deleteYuqian Li; Xinlin Liu; Fuyuan Zhang; Rong Fu; Daqiang Zhao; Li Ye; Yi Zhun Zhu
deleteShare
deleteSave
Dual-modular-nanobody CAR-T cell technical platform against the solid tumor microenvironment
delete2026-07-02
delete0
deleteOAAI
deleteYangzi Li; Xuan Wang; Shangkun Zhang; Tao Peng; Zihan Gong; Haodong Jiang; Xianing Huang; Shenxia Xie; Heng Liu; Fengzhen Mo; Tongcun Zhang; Xiaomei Yang; Xiaobing Jiang; Xiaoling Lu
deleteShare
deleteSave
KRAS inhibition is an effective therapy for appendiceal adenocarcinoma
delete2026-07-02
delete0
deleteOAAI
deleteSaikat Chowdhury; Ichiaki Ito; Vinay K. Pattalachinti; Abdelrahman M. G. Yousef; Mahmoud M. G. Yousef; Sacha El Khoury; Nicholas Hornstein; Ashlee Nichole Seldomridge; David Hong; Micheal J. Overman; Melissa W. Taggart; Wai Chin Foo; Beth Helmink; Keith F. Fournier; John Paul Shen
deleteShare
deleteSave
Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm
delete2026-07-01
delete0
deleteOAAI
deleteGuillaume Cartron; Isabelle Chaillol; Roch Houot; Yassine Al Tabaa; Fabien Le Bras; Loïc Ysebaert; Sylvain Choquet; Fabrice Jardin; Jacques-Olivier Bay; François-Xavier Gros; Franck Morschhauser; Cédric Rossi; Thomas Gastinne; Catherine Thieblemont; Magalie Joris; Laure Ricard; Caroline Regny; Laurianne Drieu La Rochelle; Pierre Feugier; Ambroise Marcais; Romain Ould-Ammar; Karin Tarte; Camille Laurent; Pierre Sesques
deleteShare
deleteSave
Long-term control of peritoneal metastases following claudin 18.2-targeted CAR T-Cell therapy in advanced gastric cancer
delete2026-07-01
delete0
deleteOAAI
deleteChang Liu; Hongxi Zeng; Jiarui Li; Panpan Zhang; Dan Liu; Miao Zhang; Ran Xue; Jifang Gong; Xiaotian Zhang; Yu Sun; Lin Shen; Changsong Qi
deleteShare
deleteSave
Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study
delete2026-06-27
delete0
deleteOAAI
deleteNicholas J. Short; Alex Bataller; Courtney D. DiNardo; Guillermo Montalban-Bravo; Sa A. Wang; Wei Wang; Abhishek Maiti; Daniel Nguyen; Maria C. Hachem; Timothy M. Bi; Ghayas C. Issa; Kelly S. Chien; Maro Ohanian; Tapan M. Kadia; Sanam Loghavi; Omer Karrar; Pavan Bachireddy; Hyunsoo Hwang; Xuelin Huang; Guillermo Garcia-Manero; Farhad Ravandi
deleteShare
deleteSave
The DAPK3-DCAF1 pathway regulates ZBP1 protein stability to orchestrate PANoptosis for ovarian cancer therapy
delete2026-06-26
delete0
deleteOAAI
deleteZhiqi Liao; Linghui Wang; Ziyan Zhang; Wenjian Gong; Mengshi Luo; Yuewen Zhang; Qiuyang Xu; Yijie Wu; Shennan Shi; Fan Xiong; Li Zhu; Xuejiao Zhao; Gordon B. Mills; Ding Ma; Dan Liu; Guang-Nian Zhao; Qinglei Gao; Yong Fang
deleteShare
deleteSave